SCHEMBL2650841

SCHEMBL2650841

CC(C)COc1ccccc1NC(=O)C(=O)Nc1nc(C(N)S(C)(=O)=O)c(Br)s1.CC(C)COc1ccccc1NC(=O)C(=O)Nc1nc(CNS(C)(=O)=O)c(Cl)s1

nearest known ligand 0.32

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.32
SLC2A1 P11166 1/20 0.31
XIAP P98170 1/20 0.30
MEN1 O00255 1/20 0.30
NPC1 O15118 1/20 0.30
RAB9A P51151 1/20 0.30
KMT2A Q03164 1/20 0.30
GRM4 Q14833 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2650844 0.92 SLC2A1 (0.34) SMN1; SMN2SLC2A1MEN1NPC1RAB9A
SCHEMBL1341862 0.90 SLC2A1 (0.37) SMN1; SMN2SLC2A1MEN1NPC1RAB9A
SCHEMBL1340323 0.89 KMT2A (0.36) SMN1; SMN2SLC2A1XIAPMEN1NPC1
SCHEMBL1340324 0.86 SLC2A1 (0.37) SMN1; SMN2SLC2A1XIAPMEN1NPC1
SCHEMBL1341860 0.86 KMT2A (0.35) SMN1; SMN2MEN1NPC1RAB9AKMT2A
SCHEMBL2652270 0.85 GCK (0.35) GRM4
SCHEMBL2649924 0.83 GCK (0.35) SMN1; SMN2MEN1NPC1RAB9AKMT2A
SCHEMBL1340874 0.82 KDM4E (0.38) SMN1; SMN2SLC2A1NPC1RAB9A
SCHEMBL1341722 0.81 SMN1; SMN2 (0.39) SMN1; SMN2MEN1NPC1RAB9AKMT2A
SCHEMBL1343475 0.80 GCK (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1531815-A1 GLUCOKINASE ACTIVATORS NOVO NORDISK A/S (DK) 2005-05-25 EP disclosed
WO-2004002481-A1 ARYL CARBONYL DERIVATIVES AS THERAPEUTIC AGENTS NOVO NORDISK A/S (DK) 2004-01-08 WO disclosed